Gene · 2203
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure and Functions of HMGB2 Protein. | Int J Mol Sci | 2023 | 37176041 | PubTator, text mining | PubMed |
| The Landscape of Aberrant Alternative Splicing Events in Steatotic Liver Graft Post Transplantation via Transcriptome-Wide Analysis. | Int J Mol Sci | 2023 | 37175922 | PubTator, text mining | PubMed |
| The function and regulation of heat shock transcription factor in Cryptococcus. | Front Cell Infect Microbiol | 2023 | 37168390 | PubTator, text mining | PubMed |
| Nonenzymatic prevention of insulin hyperresponsiveness by FBP1. | Nat Rev Endocrinol | 2023 | 37161028 | PubTator, text mining | PubMed |
| Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation. | Nat Commun | 2023 | 37147288 | PubTator, text mining | PubMed |
| A novel variant in the FBP1 gene causes fructose-1,6-bisphosphatase deficiency through increased ubiquitination. | Arch Biochem Biophys | 2023 | 37142076 | PubTator, text mining | PubMed |
| Helicobacter pylori Modulates Heptose Metabolite Biosynthesis and Heptose-Dependent Innate Immune Host Cell Activation by Multiple Mechanisms. | Microbiol Spectr | 2023 | 37129481 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma. | Exp Mol Med | 2023 | 37121965 | PubTator, text mining | PubMed |
| Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m6A Modification. | Nutrients | 2023 | 37111057 | PubTator, text mining | PubMed |
| ME2 Promotes Hepatocellular Carcinoma Cell Migration through Pyruvate. | Metabolites | 2023 | 37110198 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses. | Int J Mol Sci | 2023 | 37108625 | PubTator, text mining | PubMed |
| Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis. | Int J Mol Sci | 2023 | 37108242 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37108109 | PubTator, text mining | PubMed |
| The Identification and Clinical Value Evaluation of CYCS Related to Asthma through Bioinformatics Analysis and Functional Experiments. | Dis Markers | 2023 | 37091894 | PubTator, text mining | PubMed |
| Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness. | Cell Metab | 2023 | 37084733 | PubTator, text mining | PubMed |
| High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV. | JCI Insight | 2023 | 37079385 | PubTator, text mining | PubMed |
| Newly discovered mechanisms that mediate tumorigenesis and tumour progression: circRNA-encoded proteins. | J Cell Mol Med | 2023 | 37070530 | PubTator, text mining | PubMed |
| Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β. | Breast Cancer Res | 2023 | 37059993 | PubTator, text mining | PubMed |
| Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects. | Alzheimers Res Ther | 2023 | 37038196 | PubTator, text mining | PubMed |
| Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy. | Front Immunol | 2023 | 37006288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2203/papers?page=16